(Q45721921)

15 December 2017

title

Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

1 reference

3

1 reference

15 December 2017

Sandeep Grover

1

1 reference

15 December 2017

Naresh Nebhinani

2

1 reference

15 December 2017

Ajit Avasthi

4

1 reference

15 December 2017

Parmanand Kulhara

5

1 reference

15 December 2017

Debasish Basu

6

1 reference

15 December 2017

Surendra Kumar Mattoo

7

1 reference

15 December 2017

Savita Malhotra

8

1 reference

15 December 2017

publication date

7 January 2013

1 reference

Nordic Journal of Psychiatry

15 December 2017

published in

1 reference

15 December 2017

volume

68

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

72-77

1 reference

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

The prevalence of metabolic syndrome in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Prevalence of metabolic syndrome in bipolar disorder: an exploratory study from North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome in Italian patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

The prevalence of metabolic syndrome among psychiatric inpatients in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Atypical antipsychotics related metabolic syndrome in bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

The role of valproate in metabolic disturbances in bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome associated with schizophrenia and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Obesity among those with mental disorders: a National Institute of Mental Health meeting report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic syndrome among patients receiving clozapine: A preliminary estimate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039488.2012.754052

10.3109/08039488.2012.754052

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference